Last edition
News about "vaccine development"
SK Bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
SK bioscience has launched an Artificial Intelligence (AI)-powered initiative to improve vaccine development decisions, supporting next-generation injectable rotavirus vaccines and expanding access in Low- and Middle-Income Countries (LMICs).
Vaccine Development | 04/07/2026 | By News Bureau | 103
Replicate Bioscience has been awarded a USD 3 million grant from the Gates Foundation to advance the development of self-replicating RNA-based tuberculosis vaccines, expanding its efforts to combat major infectious diseases including TB, HIV, malaria and rabies.
Vaccine Development | 20/06/2026 | By News Bureau | 112
US FDA Approves Additional Indication for CAPVAXIVE
The US Food and Drug Administration (FDA) has approved an expanded indication for CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for children and adolescents aged 2-17 years at increased risk of pneumococcal disease, broadening protection against serious pneumococcal infections in vulnerable pediatric populations.
Vaccine Development | 20/06/2026 | By News Bureau | 123
Clover Biopharmaceuticals Completes Initial Enrollment in Phase II Trial of RSV Combination Vaccines
The Australia-based Phase II study is evaluating Clover’s protein-based combination vaccine candidates SCB-1022 and SCB-1033 targeting RSV, hMPV and PIV3 in older adults, using its proprietary Trimer-Tag technology.
Vaccine Development | 12/01/2026 | By News Bureau | 576
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy